Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SUN PHARMA ABBOTT INDIA/
SUN PHARMA
 
P/E (TTM) x 48.6 59.2 82.1% View Chart
P/BV x 15.4 5.3 293.6% View Chart
Dividend Yield % 1.4 1.0 143.5%  

Financials

 ABBOTT INDIA   SUN PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-22
SUN PHARMA
Mar-22
ABBOTT INDIA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs23,902931 2,567.7%   
Low Rs14,553593 2,455.8%   
Sales per share (Unadj.) Rs2,315.0161.1 1,436.9%  
Earnings per share (Unadj.) Rs375.914.2 2,647.9%  
Cash flow per share (Unadj.) Rs407.023.1 1,759.5%  
Dividends per share (Unadj.) Rs275.0010.00 2,750.0%  
Avg Dividend yield %1.41.3 108.9%  
Book value per share (Unadj.) Rs1,306.2200.1 652.8%  
Shares outstanding (eoy) m21.252,399.34 0.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.34.7 175.7%   
Avg P/E ratio x51.253.7 95.3%  
P/CF ratio (eoy) x47.232.9 143.5%  
Price / Book Value ratio x14.73.8 386.7%  
Dividend payout %73.270.4 103.9%   
Avg Mkt Cap Rs m408,5731,827,693 22.4%   
No. of employees `000NANA-   
Total wages/salary Rs m5,79573,008 7.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m49,193386,545 12.7%  
Other income Rs m77414,374 5.4%   
Total revenues Rs m49,967400,919 12.5%   
Gross profit Rs m10,87553,150 20.5%  
Depreciation Rs m66121,437 3.1%   
Interest Rs m1911,274 15.0%   
Profit before tax Rs m10,79744,813 24.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,81010,755 26.1%   
Profit after tax Rs m7,98734,058 23.5%  
Gross profit margin %22.113.7 160.8%  
Effective tax rate %26.024.0 108.5%   
Net profit margin %16.28.8 184.3%  
BALANCE SHEET DATA
Current assets Rs m38,530350,150 11.0%   
Current liabilities Rs m12,032172,006 7.0%   
Net working cap to sales %53.946.1 116.9%  
Current ratio x3.22.0 157.3%  
Inventory Days Days6149 4.1%  
Debtors Days Days2100 2.1%  
Net fixed assets Rs m3,541318,882 1.1%   
Share capital Rs m2132,399 8.9%   
"Free" reserves Rs m27,544477,713 5.8%   
Net worth Rs m27,756480,112 5.8%   
Long term debt Rs m02,299 0.0%   
Total assets Rs m42,072669,032 6.3%  
Interest coverage x57.536.2 159.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.6 202.4%   
Return on assets %19.45.3 368.1%  
Return on equity %28.87.1 405.6%  
Return on capital %39.69.6 414.4%  
Exports to sales %0.70-   
Imports to sales %10.20-   
Exports (fob) Rs m350NA-   
Imports (cif) Rs m5,034NA-   
Fx inflow Rs m415106,331 0.4%   
Fx outflow Rs m5,11771,874 7.1%   
Net fx Rs m-4,70234,456 -13.6%   
CASH FLOW
From Operations Rs m9,47789,845 10.5%  
From Investments Rs m-3,958-57,247 6.9%  
From Financial Activity Rs m-6,374-51,935 12.3%  
Net Cashflow Rs m-856-17,648 4.8%  

Share Holding

Indian Promoters % 0.0 54.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.1 35.6 22.6%  
FIIs % 0.2 16.0 1.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 45.5 54.9%  
Shareholders   83,526 643,512 13.0%  
Pledged promoter(s) holding % 0.0 2.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    


More on Abbott India vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs Sun Pharma Share Price Performance

Period Abbott India Sun Pharma S&P BSE HEALTHCARE
1-Day 0.19% 0.23% 0.10%
1-Month 4.69% 3.55% -0.20%
1-Year 5.09% 39.53% -6.38%
3-Year CAGR 17.01% 33.71% 20.88%
5-Year CAGR 31.67% 14.27% 11.28%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 275.0 per share. This amounted to a Dividend Payout ratio of 73.2%.

Sun Pharma paid Rs 10.0, and its dividend payout ratio stood at 70.4%.

You may visit here to review the dividend history of Abbott India, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

SGX Nifty Trades Flat | Upcoming IPOs in December | RBI Announces First Pilot for Digital Rupee | Top Buzzing Stocks Today(Pre-Open)

On Tuesday, Indian share markets witnessed positive trading activity and ended higher, taking the rally to sixth consecutive session.